Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday

Author: Avi Kapoor | December 19, 2023 11:19am

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday.

Shares of bluebird bio, Inc. (NASDAQ:BLUE) shares fell sharply during Tuesday’s session after the company announced a proposed public offering of $150 million of common stock.

bluebird bio shares dipped 14.2% to $2.6180 on Tuesday.

Here are some other big stocks recording losses in today’s session.

• CureVac N.V. (NASDAQ:CVAC) shares fell 35.7% to $3.7384. CureVac announced decision of German Federal Patent Court in broad patent litigation with BioNTech SE.
• Shengfeng Development Limited (NASDAQ:SFWL) fell 32.4% to $3.24.
• Invivyd, Inc. (NASDAQ:IVVD) tumbled 16.4% to $3.00. Morgan Stanley upgraded Invivyd from Underweight to Equal-Weight and raised the price target from $1 to $4.
• Diversified Energy Co PLC (NYSE:DEC) fell 12% to $15.77.
• Vertex Energy, Inc. (NASDAQ:VTNR) fell 10% to $3.2750. Stifel downgraded Vertex Energy from Buy to Hold and lowered the price target from $6 to $4.
• uniQure N.V. (NASDAQ:QURE) shares declined 9.8% to $7.20 after announcing updated interim data on Phase I/II clinical trials of AMT-130 gene therapy for the treatment of Huntington's disease.
• TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) fell 5.5% to $3.78. TFF Pharmaceuticals announced initial data from its ongoing Phase 2 trials of TFF VORI and TFF TAC, along with clinical data from the ongoing TFF VORI expanded access program.
• Lyft, Inc. (NASDAQ:LYFT) fell 3.8% to $15.04.
• Array Technologies, Inc. (NASDAQ:ARRY) fell 3.5% to $18.32. Piper Sandler downgraded Array Technologies from Overweight to Neutral and lowered the price target from $26 to $22.

 

Now Read This: US Stocks Higher; Accenture Issues Weak Sales Outlook

Posted In: ARRY BLUE CVAC DEC IVVD LYFT QURE SFWL TFFP VTNR